Hyperlipidemia and Mixed Dyslipidemia
1 clinical trials · Condition
◉ Watch Hyperlipidemia and Mixed Dyslipidemia
| Record | Firm | Date |
|---|---|---|
| Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia (NCT01854918) | Amgen | 2013-04-23 |
Track Hyperlipidemia and Mixed Dyslipidemia automatically
Every clearance here is in the API, with alerts when new ones post.